全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Adequacy of Cancer Screening in Adult Women with Congenital Heart Disease

DOI: 10.1155/2013/827696

Full-Text   Cite this paper   Add to My Lib

Abstract:

Adults with congenital heart disease (ACHD) face noncardiac healthcare challenges as the population ages. We assessed whether women with ACHD have comparable cancer screening rates to non-ACHD women in a cardiac practice and to the general population. We performed a retrospective review of 175 adult women seen in a cardiac care center in 2009–2011. Data on Pap tests, mammography, and colonoscopies, were collected through electronic medical records and primary care provider records. Adequate documentation was available for 100 individuals with ACHD and 40 comparator cardiac patients. The adequacy of screening was determined using guidelines set forth by the American Cancer Society in 2010. Compared with the national average, ACHD patients had significantly lower rates of Pap tests (60% versus 83%, ) and mammography (48% versus 72%, ). Compared with non-ACHD women in the same practice, ACHD patients had consistently lower rates of mammography (48% versus 81%, ) and colonoscopies (54% versus 82%, ). As the population of ACHD individuals ages, attention to cancer screening becomes increasingly important but may be overlooked in this population. Primary care physicians and cardiologists should collaborate to ensure appropriate cancer screening for this growing population. 1. Background As a result of surgical advances as well as improvements in diagnosis and medical management, there may now be over 1 million adults with congenital heart disease in the United States, and this population is rapidly expanding [1]. As this population ages, the annual incidence of age-related malignancy rises, and caregivers must now ensure adequate and timely preventive cancer screening for the adult congenital heart disease (ACHD) patient. Primary care of the ACHD patient may be overshadowed by late cardiac complications including arrhythmia, valvular disease, and heart failure [2, 3]. The European Society of Cardiology and 2008 American College of Cardiology/American Heart Association guidelines have both called for increased access to primary care physicians and attention to health maintenance [4, 5]. To develop strategies to improve overall screening, it is essential to identify groups of individuals with inadequate screening rates and to assess potential barriers to preventive screening. Known risk factors for poor participation in preventive screening include low socioeconomic status, lower levels of education, immigrant status, lack of health insurance and importantly, lack of a primary care provider [6]. Individuals with chronic disease rely on subspecialists for their

References

[1]  J. I. E. Hoffman, S. Kaplan, and R. R. Liberthson, “Prevalence of congenital heart disease,” American Heart Journal, vol. 147, no. 3, pp. 425–439, 2004.
[2]  C. L. Verheugt, C. S. P. M. Uiterwaal, E. T. Van Der Velde et al., “Mortality in adult congenital heart disease,” European Heart Journal, vol. 31, no. 10, pp. 1220–1229, 2010.
[3]  P. Pillutla, K. D. Shetty, and E. Foster, “Mortality associated with adult congenital heart disease: trends in the US population from 1979 to 2005,” American Heart Journal, vol. 158, no. 5, pp. 874–879, 2009.
[4]  “ESC Guidelines for the Management of Grown-Up Congenital Heart Disease,” European Heart Journal, vol. 31, pp. 2915–2957, 2010.
[5]  C. A. Warnes, R. G. Williams, T. M. Bashore et al., “ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary,” Circulation, vol. 118, no. 23, pp. 2395–2451, 2008.
[6]  M. M. Amonkar, S. Madhavan, S. A. Rosenbluth, and K. J. Simon, “Barriers and facilitators to providing common preventive screening services in managed care settings,” Journal of Community Health, vol. 24, no. 3, pp. 229–247, 1999.
[7]  M. T. Britto, J. M. Garrett, M. A. J. Dugliss, C. A. Johnson, J. M. Majure, and M. W. Leigh, “Preventive services received by adolescents with cystic fibrosis and sickle cell disease,” Archives of Pediatrics and Adolescent Medicine, vol. 153, no. 1, pp. 27–32, 1999.
[8]  A. N. Sheth, R. D. Moore, and K. A. Gebo, “Provision of general and HIV-specific health maintenance in middle aged and older patients in an urban HIV clinic,” AIDS Patient Care and STDs, vol. 20, no. 5, pp. 318–325, 2006.
[9]  J. G. Marshall, J. M. Cowell, E. S. Campbell, and D. B. McNaughton, “Regional variations in cancer screening rates found in women with diabetes,” Nursing Research, vol. 59, no. 1, pp. 34–41, 2010.
[10]  C. C. Earle and B. A. Neville, “Under use of necessary care among cancer survivors,” Cancer, vol. 101, no. 8, pp. 1712–1719, 2004.
[11]  A. S. Mackie, R. Ionescu-Ittu, J. Therrien, L. Pilote, M. Abrahamowicz, and A. J. Marelli, “Children and adults with congenital heart disease lost to follow-up: who and when?” Circulation, vol. 120, no. 4, pp. 302–309, 2009.
[12]  S. M. Fernandes and M. J. Landzberg, “Transitioning the young adult with congenital heart disease for life-long medical care,” Pediatric Clinics of North America, vol. 51, no. 6, pp. 1739–1748, 2004.
[13]  G. J. Reid, M. J. Irvine, B. W. McCrindle et al., “Prevalence and correlates of successful transfer from pediatric to adult health care among a cohort of young adults with complex congenital heart defects,” Pediatrics, vol. 113, no. 3, pp. e197–e205, 2004.
[14]  R. A. Smith, V. Cokkinides, D. Brooks, D. Saslow, and O. W. Brawley, “Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening,” CA Cancer Journal for Clinicians, vol. 60, no. 2, pp. 99–119, 2010.
[15]  ACOG Committee on Practice Bulletins-Gynecology, “ACOG Practice Bulletin no. 109: cervical cytology screening,” Obstetrics & Gynecology, vol. 114, no. 6, pp. 1409–1420, 2009.
[16]  US Preventive Services Task Force (USPSTF), “Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement,” Annals of Internal Medicine, vol. 149, no. 9, pp. 627–637, 2008.
[17]  US Preventive Services Task Force (USPSTF), “1) Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. 2) December 2009 addendum,” Annals of Internal Medicine, vol. 151, no. 10, pp. 716–726, 2009.
[18]  C. H. Lee, D. D. Dershaw, D. Kopans et al., “Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer,” Journal of the American College of Radiology, vol. 7, no. 1, pp. 18–27, 2010.
[19]  ACOG Committee on Practice Bulletins-Gynecology, “ACOG Practice bulletin no. 122: breast cancer screening,” Obstetrics & Gynecology, vol. 118, no. 2, Part 1, p. 372, 2011.
[20]  C. A. Warnes, R. Liberthson, G. K. Danielson et al., “Task force 1: the changing profile of congenital heart disease in adult life,” Journal of the American College of Cardiology, vol. 37, no. 5, pp. 1170–1175, 2001.
[21]  US Department of Health and Human Services, “Healthy People 2010 topics and objectives: cancer,” DATA2010—the Healthy People 2010 Database, U.S. Department of Health and Human Services, Washington, DC, USA, October 2011, http://wonder.cdc.gov/data2010/.
[22]  Centers for Disease Control and Prevention, “Cancer Screening—United States, 2010,” Morbidity and Mortality Weekly Report, vol. 61, pp. 41–45, 2012.
[23]  EpiCalc 2000, Brixton Health, http://www.brixtonhealth.com/epicalc.html.
[24]  D. A. Redelmeier, S. H. Tan, and G. L. Booth, “The treatment of unrelated disorders in patients with chronic medical diseases,” New England Journal of Medicine, vol. 338, no. 21, pp. 1516–1520, 1998.
[25]  US Department of Health and Human Services, “Healthy People 2020 topics and objectives: cancer,” US Department of Health and Human Services, Washington, DC, USA, 2011, http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=5.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133